ArticleInvestigative ophthalmology & visual science2025
Identifying Retinal Features Using a Self-Configuring CNN for Clinical Intervention.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Digital Volume Correlation Challenge 2.0: A Comprehensive Dataset for Digital Volume Correlation Benchmarking.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Purpose: Retinal diseases are leading causes of blindness worldwide, necessitating accurate diagnosis and timely treatment. Optical coherence tomography (OCT) has become a universal imaging modality of the retina in the past 2 decades, aiding in the diagnosis of various retinal conditions. However, the scarcity of comprehensive, annotated OCT datasets, that are labor-intensive to assemble, has hindered the advancement of artificial intelligence (AI)-based diagnostic tools. Methods: To address the lack of annotated OCT segmentation datasets, we introduce OCTAVE, an extensive 3D OCT dataset with high-quality, pixel-level annotations for anatomic and pathological structures. Additionally, we provide similar annotations for four independent public 3D OCT datasets, enabling their use as external validation sets. To demonstrate the potential of this resource, we train a deep learning segmentation model using the self-configuring no-new-U-Net (nnU-Net) framework and evaluate its performance across all four external validation sets. Results: The OCTAVE dataset collected consists of 198 OCT volumes (3762 B-scans) used for training and 221 OCT volumes (4109 B-scans) for external validation. The trained deep learning model demonstrates clinically significant performance across all retinal structures and pathological features. Conclusions: We demonstrate robust segmentation performance and generalizability across independently collected datasets. OCTAVE bridges the gap in publicly available datasets, supporting the development of AI tools for precise disease detection, monitoring, and treatment guidance. This resource has the potential to improve clinical outcomes and advance AI-driven retinal disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.